PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Amanta Healthcare Limited

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Amanta Healthcare Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.

What stands out

  • Profit Cash Ratio: Over the last 3 years, every ₹100 of reported profit came with ₹528 of operating cash. Higher than 98% of Healthcare companies in India.
  • Growth Efficiency Ratio: Sales grew 10% in 3 years; of every extra ₹100 of sales, ₹64 became extra profit. Higher than 96% of Healthcare companies in India.
  • Cash Cushion Ratio: Debt, after subtracting cash, equals 25% of its market value (net debt). Lower than 94% of Healthcare companies in India.

Where ₹100 of sales goes

₹86Operating costs₹7.0Interest₹5.2Net profit₹0.1Paid as dividends

Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

₹528

Over the last 3 years, every ₹100 of reported profit came with ₹528 of operating cash.

Higher than 98% of Healthcare companies in India.

Self-Funding Ratio

1.3×

Over the last 3 years its own operating cash covered its investment spending (capex) 1.3 times.

Lower than 51% of Healthcare companies in India.

Cash Locked Ratio

₹28

For every ₹100 of sales, ₹28 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹31 tied up three years earlier.

More money tied up than 56% of Healthcare companies in India.

Growth quality

Steadiness Ratio

2/3 · 3/3

Sales grew in 2 of the last 3 years; profit grew in 3 of 3.

Steadier than 53% of Healthcare companies in India.

Growth Efficiency Ratio

₹64

Sales grew 10% in 3 years; of every extra ₹100 of sales, ₹64 became extra profit.

Higher than 96% of Healthcare companies in India.

Asset Productivity Ratio

+10% / +49%

In 3 years sales changed by +10% while total assets changed by +49%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

0.7×

Debt due within a year is covered 0.7 times by its yearly operating cash.

Lower than 63% of Healthcare companies in India.

Cash Cushion Ratio

−25%

Debt, after subtracting cash, equals 25% of its market value (net debt).

Lower than 94% of Healthcare companies in India.

Tangible Assets Ratio

100%

Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 79% of Healthcare companies in India.

Tangible Net Worth Ratio

100%

Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 75% of Healthcare companies in India.

Shareholders

Shareholder Slice Ratio

0%

Share count was unchanged over the last 3 years. Dividends paid equalled 8% of profit over the same period.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Amanta Healthcare Limited owes ₹0.61 for every ₹1 it owns. Net profit rose 42% in the year to Mar 2026.

Compared with Healthcare companies in India · latest annual results Mar 2026.

P/E ratio

39.6

Investors pay ₹39.6 for every ₹1 of Amanta Healthcare Limited's yearly profit, higher than 55% of Healthcare companies in India.

P/B ratio

2.91

The share price is 2.91 times Amanta Healthcare Limited's book value per share, lower than 72% of Healthcare companies in India.

Market cap

₹640 Cr

The total market value of all of Amanta Healthcare Limited's shares at today's price (share price × number of shares), smaller than 86% of Healthcare companies in India. PosiCap size class: Micro Cap.

Net worth (book value)

₹220 Cr

What Amanta Healthcare Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).

Book value per share

₹56.71

Net worth divided by the number of shares. The share price of ₹164.88 is 2.9 times this, which is the P/B above.

Return on equity (ROE)

6.5%

Amanta Healthcare Limited earned 6.5% on its shareholders' money over the last year, lower than 80% of Healthcare companies in India.

Owes vs Owns

0.61×

Amanta Healthcare Limited owes ₹0.61 for every ₹1 it owns (moderate), higher than 92% of Healthcare companies in India.

Dividend yield

None

Amanta Healthcare Limited does not currently pay a dividend.

Revenue growth

+4%

Revenue rose 4% in the year to Mar 2026, and grew 3% a year on average over 3 years.

Profit growth

+42%

Net profit rose 42% in the year to Mar 2026.

Profit margin

5.2%

Amanta Healthcare Limited keeps ₹5 of every ₹100 of revenue as net profit.

Cash quality

3.3×

Cash from Amanta Healthcare Limited's business was 3.3× its reported profit in the year to Mar 2026 — its profit turned into cash.

Interest cover

2.1×

Amanta Healthcare Limited's operating profit covered its interest costs 2.1 times in the year to Mar 2026.

Cash vs debt

Net debt

Amanta Healthcare Limited had ₹162 Cr more debt than cash (net debt) at Mar 2026.

Questions

What is Amanta Healthcare Limited's P/E ratio?

Investors pay ₹39.6 for every ₹1 of Amanta Healthcare Limited's yearly profit, higher than 55% of Healthcare companies in India.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Amanta Healthcare Limited: ₹640 Cr ÷ ₹220 Cr (31 Mar 2026) = 2.9.

What is Amanta Healthcare Limited's return on equity?

Amanta Healthcare Limited earned 6.5% on its shareholders' money over the last year, lower than 80% of Healthcare companies in India.

How much does Amanta Healthcare Limited owe compared with what it owns?

Amanta Healthcare Limited owes ₹0.61 for every ₹1 it owns (moderate), higher than 92% of Healthcare companies in India.

Does Amanta Healthcare Limited pay a dividend?

No. Amanta Healthcare Limited does not currently pay a dividend.

Is Amanta Healthcare Limited's revenue growing?

Revenue rose 4% in the year to Mar 2026, and grew 3% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.